Jeske WP - Search Results

1

Clinical experience with combined treatment of thrombin inhibitors and GPIIb/IIIa inhibitors in patients with HIT.

Walenga JM, Jeske WP, Wallis DE, Bakhos M, Lewis BE, Leya F, Fareed J. Walenga JM, et al. Among authors: jeske wp. Semin Thromb Hemost. 1999;25 Suppl 1:77-81. Semin Thromb Hemost. 1999. PMID: 10357156

2

Effect of glycoprotein IIb/IIIa antagonists on the HIT serum induced activation of platelets.

Jeske WP, Walenga JM, Szatkowski E, Ero M, Herbert JM, Haas S, Bakhos M. Jeske WP, et al. Thromb Res. 1997 Nov 1;88(3):271-81. doi: 10.1016/s0049-3848(97)00254-5. Thromb Res. 1997. PMID: 9526947

3

Laboratory tests for heparin-induced thrombocytopenia: a multicenter study.

Walenga JM, Jeske WP, Wood JJ, Ahmad S, Lewis BE, Bakhos M. Walenga JM, et al. Among authors: jeske wp. Semin Hematol. 1999 Jan;36(1 Suppl 1):22-8. Semin Hematol. 1999. PMID: 9930560 Clinical Trial.

4

Selectins in the HIT syndrome: pathophysiologic role and therapeutic modulation.

Fareed J, Walenga JM, Hoppensteadt DA, Jeske WP, Lietz H, Ahmad S, Callas D, Messmore HL, Haas S. Fareed J, et al. Among authors: jeske wp. Semin Thromb Hemost. 1999;25 Suppl 1:37-42. Semin Thromb Hemost. 1999. PMID: 10357150 Review.

5

Laboratory tests for the diagnosis of heparin-induced thrombocytopenia.

Walenga JM, Jeske WP, Fasanella AR, Wood JJ, Bakhos M. Walenga JM, et al. Among authors: jeske wp. Semin Thromb Hemost. 1999;25 Suppl 1:43-9. Semin Thromb Hemost. 1999. PMID: 10357151

6

Comparison of two PF4/heparin ELISA assays for the laboratory diagnosis of heparin-induced thrombocytopenia.

Izban KF, Lietz HW, Hoppensteadt DA, Jeske WP, Fareed J, Bakhos M, Walenga JM. Izban KF, et al. Among authors: jeske wp. Semin Thromb Hemost. 1999;25 Suppl 1:51-6. Semin Thromb Hemost. 1999. PMID: 10357152

7

Heparin-induced thrombocytopenia: the role of platelet activation and therapeutic implications.

Haas S, Walenga JM, Jeske WP, Fareed J. Haas S, et al. Among authors: jeske wp. Semin Thromb Hemost. 1999;25 Suppl 1:67-75. Semin Thromb Hemost. 1999. PMID: 10357155

8

Heparin-induced thrombocytopenia: clinical considerations of alternative anticoagulation with various glycosaminoglycans and thrombin inhibitors.

Haas S, Walenga JM, Jeske WP, Fareed J. Haas S, et al. Among authors: jeske wp. Clin Appl Thromb Hemost. 1999 Jan;5(1):52-9. doi: 10.1177/107602969900500111. Clin Appl Thromb Hemost. 1999. PMID: 10725984 Free article. Review.

9

Simultaneous monitoring of argatroban and its major metabolite using an HPLC method: potential clinical applications.

Ahmad S, Ahsan A, George M, Iqbal O, Jeske WP, McKenna R, Lewis BE, Walenga JM, Fareed J. Ahmad S, et al. Among authors: jeske wp. Clin Appl Thromb Hemost. 1999 Oct;5(4):252-8. doi: 10.1177/107602969900500409. Clin Appl Thromb Hemost. 1999. PMID: 10726023 Free article.

10

Synthetic pentasaccharides do not cause platelet activation by antiheparin-platelet factor 4 antibodies.

Ahmad S, Jeske WP, Walenga JM, Hoppensteadt DA, Wood JJ, Herbert JM, Messmore HL, Fareed J. Ahmad S, et al. Among authors: jeske wp. Clin Appl Thromb Hemost. 1999 Oct;5(4):259-66. doi: 10.1177/107602969900500410. Clin Appl Thromb Hemost. 1999. PMID: 10726024 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

123 results

Search Page

Filters